Marino Venerito

5.2k total citations
100 papers, 1.8k citations indexed

About

Marino Venerito is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marino Venerito has authored 100 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Surgery, 44 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Marino Venerito's work include Helicobacter pylori-related gastroenterology studies (46 papers), Gastric Cancer Management and Outcomes (29 papers) and Eosinophilic Esophagitis (16 papers). Marino Venerito is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (46 papers), Gastric Cancer Management and Outcomes (29 papers) and Eosinophilic Esophagitis (16 papers). Marino Venerito collaborates with scholars based in Germany, Italy and Greece. Marino Venerito's co-authors include Peter Malfertheiner, Theodoros Rokkas, Arne Kandulski, Alexander Link, Riccardo Vasapolli, Thomas Wex, Rosa Rosania, Gioacchino Leandro, Costanza Chiapponi and Michael Selgrad and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Marino Venerito

91 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marino Venerito Germany	23	1.1k	622	421	321	279	100	1.8k
Hyun Joo Jang South Korea	25	847 0.8×	630 1.0×	456 1.1×	385 1.2×	288 1.0×	120	1.8k
Arne Kandulski Germany	23	1.2k 1.1×	373 0.6×	704 1.7×	164 0.5×	214 0.8×	119	1.8k
Manuel Castro de Moura Spain	21	1.1k 1.1×	527 0.8×	779 1.9×	400 1.2×	486 1.7×	51	2.8k
Hideyuki Tamai Japan	26	1.5k 1.4×	1.1k 1.8×	365 0.9×	326 1.0×	279 1.0×	92	2.3k
Chien‐Yu Lu Taiwan	24	739 0.7×	457 0.7×	209 0.5×	650 2.0×	309 1.1×	61	1.6k
Gerhard Treiber Germany	23	1.2k 1.1×	462 0.7×	680 1.6×	199 0.6×	189 0.7×	72	1.7k
Chu‐Kuang Chou Taiwan	15	857 0.8×	663 1.1×	233 0.6×	407 1.3×	174 0.6×	59	1.4k
Mihoko Yamade Japan	23	1.1k 1.1×	477 0.8×	718 1.7×	242 0.8×	248 0.9×	106	1.7k
Nobuo Aoyama Japan	28	1.2k 1.2×	425 0.7×	472 1.1×	1.2k 3.9×	566 2.0×	98	3.0k
Giulia Martina Cavestro Italy	27	1.2k 1.2×	268 0.4×	296 0.7×	621 1.9×	173 0.6×	89	1.8k

Countries citing papers authored by Marino Venerito

Since Specialization

Citations

This map shows the geographic impact of Marino Venerito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marino Venerito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marino Venerito more than expected).

Fields of papers citing papers by Marino Venerito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marino Venerito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marino Venerito. The network helps show where Marino Venerito may publish in the future.

Co-authorship network of co-authors of Marino Venerito

This figure shows the co-authorship network connecting the top 25 collaborators of Marino Venerito. A scholar is included among the top collaborators of Marino Venerito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marino Venerito. Marino Venerito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosania, Rosa, Mark Nord, Florian G. Scurt, et al.. (2025). Risk Factors for Intestinal and Extraintestinal Cancers in Inflammatory Bowel Disease: A Retrospective Single-Center Cohort Study. Cancers. 17(9). 1396–1396.

Himmelsbach, Vera, Bernhard Scheiner, Matthias Pinter, et al.. (2024). Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial. Cancers. 16(13). 2442–2442. 3 indexed citations

Muller, Christian D., et al.. (2024). Imatinib induces clinical response in a patient with refractory combined hepatocellular and cholangiocellular carcinoma harbouring a rare PDGFRA exon 18 mutation (p.I843_S847delinsT). Zeitschrift für Gastroenterologie. 62(1). e38–e38.

Scarpa, Alfonso, Rita T. Lawlor, Anguraj Sadanandam, et al.. (2024). 1150P Search for biomarkers to personalize treatment with streptozotocin plus 5-fluorouracil or everolimus in patients with advanced pancreatic neuroendocrine tumors: The randomized phase III SEQTOR trial (GETNE-1206). Annals of Oncology. 35. S754–S754. 2 indexed citations

Krogh, Merete, Àlex Teulé, Heinz‐Josef Klümpen, et al.. (2024). 1142O Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206). Annals of Oncology. 35. S750–S750. 1 indexed citations

Berres, Marie‐Luise, Maria A. González-Carmona, Dominik Paul Modest, et al.. (2023). Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC). BMC Cancer. 23(1). 470–470. 2 indexed citations

Müller, Christian, Jazan Omari, Konrad Mohnike, et al.. (2023). Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience. Cancers. 15(9). 2598–2598. 3 indexed citations

Himmelsbach, Vera, Matthias Pinter, Bernhard Scheiner, et al.. (2022). Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers. Cancers. 14(7). 1722–1722. 34 indexed citations

Reinacher‐Schick, Anke, et al.. (2022). Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice. Oncology Research and Treatment. 45(12). 752–763. 1 indexed citations

10.

Trojan, Jörg, Patrick Mollon, Bruno Daniele, et al.. (2021). Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison. Advances in Therapy. 38(5). 2472–2490. 11 indexed citations

11.

Powerski, Maciej, et al.. (2020). Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options. Best Practice & Research Clinical Gastroenterology. 48-49. 101711–101711. 9 indexed citations

12.

Haag, Georg Martin, Sylvie Lorenzen, Thomas J. Ettrich, et al.. (2020). 1447P S-1 maintenance therapy in non-Asian patients with advanced, Her-2 negative esophagogastric adenocarcinoma – First results of the international MATEO trial initiated by the AIO. Annals of Oncology. 31. S910–S910. 2 indexed citations

13.

Venerito, Marino. (2019). S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study. Drugs in R&D. 19(2). 141–148. 3 indexed citations

14.

Bornschein, Jan, Lorenz Wernisch, Maria Secrier, et al.. (2019). Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction. International Journal of Cancer. 145(12). 3389–3401. 14 indexed citations

15.

Vadhan‐Raj, Saroj, Mairéad G. McNamara, Marino Venerito, et al.. (2019). Rivaroxaban thromboprohylaxis in ambulatory patients with pancreatic cancer: Results from a prespecified subgroup analysis of the CASSINI study.. Journal of Clinical Oncology. 37(15_suppl). 4016–4016. 8 indexed citations

16.

Venerito, Marino, et al.. (2017). Recurrent diffuse gastric bleeding as a leading symptom of gastrointestinal AL amyloidosis. Zeitschrift für Gastroenterologie. 55(12). 1318–1322. 5 indexed citations

17.

Venerito, Marino, Dörthe Jechorek, Thomas Wex, et al.. (2016). Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study. BMC Gastroenterology. 16(1). 85–85. 12 indexed citations

18.

Venerito, Marino, Thomas Wex, & Peter Malfertheiner. (2011). Helicobacter pylori related and non-related lesions in the stomach.. PubMed. 57(4). 395–403. 4 indexed citations

19.

Kandulski, Arne, Marino Venerito, & Peter Malfertheiner. (2010). Therapeutic strategies for the treatment of dyspepsia. Expert Opinion on Pharmacotherapy. 11(15). 2517–2525. 4 indexed citations

20.

Tsochatzis, Emmanuel, Marino Venerito, George Papatheodoridis, et al.. (2006). Hepatobiliary and pancreatic: Spontaneous splenorenal shunts in portal hypertension. Journal of Gastroenterology and Hepatology. 21(7). 1214–1214. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact